Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): Baseline characteristics, prognosis and response to therapy in the vasodilator in heart failure trials (V-HeFT)

Journal of the American College of Cardiology

Volumn 27, Issue 3, 1996, Pages 642-649

  Carson, Peter ^a   Johnson, Gary ^a   Fletcher, Ross ^a   Cohn, Jay ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; PRAZOSIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; VASODILATATION;

AGED; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; HYDRALAZINE; ISOSORBIDE DINITRATE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0029897872     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00503-X     Document Type: Article

References (36)

1. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe heart failure: results of the Co-operative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
2. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468-75.
3. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
4. Feldman AM, Bristow MR, Parmley WM, et al. Results of a multi-center study of OPC-8212 in chronic congestive heart failure. N Engl J Med 1993;329:149-55.
5. The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988;259:539-44.
6. Echeverria HH, Bilsker MS, Myerburg RJ, Kessler KM. Congestive heart failure: echocardiographic insights. Am J Med 1983;75:750-5.
7. Soufer R, Wohlgelernter D, Vita NA, et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985;55:1032-6.
8. Kessler KM. Heart failure with normal systolic function. Intern Med 1988;248:2109-11.
9. U.S. Department of Health and Human Services. Heart Failure Evaluation and Care of Patients With Left Ventricular Systolic Dysfunction. Clinical Practice Guidelines No. 11. Washington, DC: US Government Printing Office, 1994.
10. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986;314:1547-52.
11. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorhide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
12. Cohn JN, Johnson G. Heart failure with normal ejection fraction: The V-HeFT study. Circulation 1990;81: Suppl III:III-48-53.
13. Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G, and the V-HeFT V Cooperative Studies Group. Mechanism of death in heart failure: The Vasodilator-Heart Failure Trials. Circulation 1993;87: Suppl. V:V1-17.
14. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-202.
15. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
16. Setaro JF, Saufer R, Remetz MS, Parlmutter RA, Zaret BL. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 1992;69:1212-6.
17. Benedict CR, Weiner DH, Johnstone DE, et al. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the studies of left ventricular dysfunction (SOLVD) registry. J Am Coll Cardiol 1993;22:146A-53A.
18. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activators in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 1990;82:1724-9.
19. Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989;14:564-70.
20. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990;65:42I-8I.
21. Packer M. Lack of relations between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 1992;85 Suppl I:I-50-6.
22. Fonarow G, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilator with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C Trial. J Am Coll Cardiol 1992;19:842-50.
23. Khatri I, Uemura N, Notargiacomo A, Fries E. Direct and reflex cardiostimulating effects of hydralazine. Am J Cardiol 1977;40:38-42.
24. Zicsche S, Rector TS, Cohn JN. Interobserver discordance in the classification of mechanisms of death in studies of heart failure. J Cardiac Failure 1996;1:127-32.
25. Francis G, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A, and the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure: Relation to survival and the effects of therapy in V-HeFT II. Circulation 1993;87: Suppl VI:VI-40-8.
26. Pouleur H, Rousseau MF, Eyll C, et al, for the SOLVD Investigators. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. Circulation 1993;88:481-91.
27. Yusuf S, Peone CJ, Garies C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fraction. Lancet 1992;340:1173-8.
28. Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson PE, Cohn JN, and the V-HeFT VA Cooperative Studies Group. Enalapril decreases prevalence tachycardia in patients with chronic congestive heart failure. Circulation 1993;87: Suppl VI:VI-49-55.
29. Webster MWI, Fitzpatrick A, Nicholls MD, Ikram H, Wells JE. Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol 1985;56:566-9.
30. Cleland JGF, Dargie HJ, Ball SG, et al. Effects of enalapril in heart failure; A double-blind study of effects on exercise performance, renal function, hormones and metabolic state. Br Heart J 1985;54:305-12.
31. Cleland JGF, Dargie HJ, Hodsman GP, et al. Captopril in heart failure: A double-blind controlled trial. Br Heart J 1984;52:530-5.
32. Pfeffer MA, Braunwald E, Move LA, et al. Effect of captopril on mortality in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327: 669-77.
33. Packer M, Rouleau JL, Move LA, et al. Effects of captopril on ventricular arrhythmias and sudden death in patients with left ventricular dysfunction after myocardial infarction: SAVE trial [abstract]. J Am Coll Cardiol 1993;21:130A.
34. Pratt C, Gardner M, Pepine C, et al. Lack of ventricular arrhythmia reduction by enalapril in heart failure patients. Am J Cardiol 1995;75: 1244-9.
35. Carson PE, Johnson GR, Fletcher RD, Cohn JN, and the V-HeFT VA Cooperative Studies Group. Prognostic value of serial Holler monitors in congestive heart failure: V-HeFT. Circulation 1994;90 Suppl I:I-339A.
36. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.